Gritstone Oncology Inc
Biotechnology
Healthcare
GRTS
115 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.06
52 week high
3.92
high
2.29
52 week low
1.32
low
2.01
growth
-35.50 %
previous Close
2.04
P/E ratio
market cap
165 M
div yield
0
usd
Jun 2023
qoq
revenue
400 K
-26.20 %
net incoming
-35.26 M
-3.72 %
eps
0.00 %
-3.33 %
eps surprise
11.43 %
net profit margin
-8814.00 %
-2542.00 %
operating incoming
-35.73 M
-2.62 %
net change in cash
-5.35 M
47.87 %
cash on hand
41.41 M
-12.12 %
cost of revenue
-1.56 M
18.20 %
top top